Literature DB >> 29106591

Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.

Yu Xiang1, Youqiong Ye1, Yanyan Lou2, Yang Yang3, Chunyan Cai4, Zhao Zhang1, Tingting Mills1, Ning-Yuan Chen1, Yoonjin Kim1, Fatma Muge Ozguc1, Lixia Diao3, Harry Karmouty-Quintana1, Yang Xia1, Rodney E Kellems1, Zheng Chen1, Michael R Blackburn1, Seung-Hee Yoo1, Ann-Bin Shyu1, Gordon B Mills5, Leng Han1.   

Abstract

Background: Alternative polyadenylation (APA) is emerging as a major post-transcriptional mechanism for gene regulation, and dysregulation of APA contributes to several human diseases. However, the functional consequences of APA in human cancer are not fully understood. Particularly, there is no large-scale analysis in cancer cell lines.
Methods: We characterized the global APA profiles of 6398 patient samples across 17 cancer types from The Cancer Genome Atlas and 739 cancer cell lines from the Cancer Cell Line Encyclopedia. We built a linear regression model to explore the correlation between APA factors and APA events across different cancer types. We used Spearman correlation to assess the effects of APA events on drug sensitivity and the Wilcoxon rank-sum test or Cox proportional hazards model to identify clinically relevant APA events.
Results: We revealed a striking global 3'UTR shortening in cancer cell lines compared with tumor samples. Our analysis further suggested PABPN1 as the master regulator in regulating APA profile across different cancer types. Furthermore, we showed that APA events could affect drug sensitivity, especially of drugs targeting chromatin modifiers. Finally, we identified 1971 clinically relevant APA events, as well as alterations of APA in clinically actionable genes, suggesting that analysis of the complexity of APA profiles could have clinical utility. Conclusions: Our study highlights important roles for APA in human cancer, including reshaping cellular pathways and regulating specific gene expression, exemplifying the complex interplay between APA and other biological processes and yielding new insights into the action mechanism of cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29106591      PMCID: PMC6059203          DOI: 10.1093/jnci/djx223

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  57 in total

1.  Molecular architecture of the human pre-mRNA 3' processing complex.

Authors:  Yongsheng Shi; Dafne Campigli Di Giammartino; Derek Taylor; Ali Sarkeshik; William J Rice; John R Yates; Joachim Frank; James L Manley
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

2.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

Review 3.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 4.  Mechanisms and consequences of alternative polyadenylation.

Authors:  Dafne Campigli Di Giammartino; Kensei Nishida; James L Manley
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 5.  Emerging Themes in Regulation of Global mRNA Turnover in cis.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Trends Biochem Sci       Date:  2016-09-16       Impact factor: 13.807

Review 6.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Authors:  D Chen; M Frezza; S Schmitt; J Kanwar; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

7.  Biased chromatin signatures around polyadenylation sites and exons.

Authors:  Noah Spies; Cydney B Nielsen; Richard A Padgett; Christopher B Burge
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

8.  The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis.

Authors:  Mehmet Bakircioglu; Ofélia P Carvalho; Maryam Khurshid; James J Cox; Beyhan Tuysuz; Tanyeri Barak; Saliha Yilmaz; Okay Caglayan; Alp Dincer; Adeline K Nicholas; Oliver Quarrell; Kelly Springell; Gulshan Karbani; Saghira Malik; Caroline Gannon; Eamonn Sheridan; Moira Crosier; Steve N Lisgo; Susan Lindsay; Kaya Bilguvar; Fanni Gergely; Murat Gunel; C Geoffrey Woods
Journal:  Am J Hum Genet       Date:  2011-04-28       Impact factor: 11.025

9.  Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Authors:  Eliezer M Van Allen; Nikhil Wagle; Petar Stojanov; Danielle L Perrin; Kristian Cibulskis; Sara Marlow; Judit Jane-Valbuena; Dennis C Friedrich; Gregory Kryukov; Scott L Carter; Aaron McKenna; Andrey Sivachenko; Mara Rosenberg; Adam Kiezun; Douglas Voet; Michael Lawrence; Lee T Lichtenstein; Jeff G Gentry; Franklin W Huang; Jennifer Fostel; Deborah Farlow; David Barbie; Leena Gandhi; Eric S Lander; Stacy W Gray; Steven Joffe; Pasi Janne; Judy Garber; Laura MacConaill; Neal Lindeman; Barrett Rollins; Philip Kantoff; Sheila A Fisher; Stacey Gabriel; Gad Getz; Levi A Garraway
Journal:  Nat Med       Date:  2014-05-18       Impact factor: 53.440

10.  Correlating chemical sensitivity and basal gene expression reveals mechanism of action.

Authors:  Matthew G Rees; Brinton Seashore-Ludlow; Jaime H Cheah; Drew J Adams; Edmund V Price; Shubhroz Gill; Sarah Javaid; Matthew E Coletti; Victor L Jones; Nicole E Bodycombe; Christian K Soule; Benjamin Alexander; Ava Li; Philip Montgomery; Joanne D Kotz; C Suk-Yee Hon; Benito Munoz; Ted Liefeld; Vlado Dančík; Daniel A Haber; Clary B Clish; Joshua A Bittker; Michelle Palmer; Bridget K Wagner; Paul A Clemons; Alykhan F Shamji; Stuart L Schreiber
Journal:  Nat Chem Biol       Date:  2015-12-14       Impact factor: 15.040

View more
  44 in total

1.  Recent molecular insights into canonical pre-mRNA 3'-end processing.

Authors:  Yadong Sun; Keith Hamilton; Liang Tong
Journal:  Transcription       Date:  2020-06-11

2.  Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.

Authors:  Jingjing Huang; Tingting Weng; Junsuk Ko; Ning-Yuan Chen; Yu Xiang; Kelly Volcik; Leng Han; Michael R Blackburn; Xiang Lu
Journal:  Biochem Biophys Res Commun       Date:  2018-06-23       Impact factor: 3.575

3.  Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.

Authors:  Tingting Weng; Junsuk Ko; Chioniso P Masamha; Zheng Xia; Yu Xiang; Ning-Yuan Chen; Jose G Molina; Scott Collum; Tinne C Mertens; Fayong Luo; Kemly Philip; Jonathan Davies; Jingjing Huang; Cory Wilson; Rajarajan A Thandavarayan; Brian A Bruckner; Soma Sk Jyothula; Kelly A Volcik; Lei Li; Leng Han; Wei Li; Shervin Assassi; Harry Karmouty-Quintana; Eric J Wagner; Michael R Blackburn
Journal:  J Clin Invest       Date:  2019-02-28       Impact factor: 14.808

4.  Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.

Authors:  Junsuk Ko; Tingting Mills; Jingjing Huang; Ning-Yuan Chen; Tinne C J Mertens; Scott D Collum; Garam Lee; Yu Xiang; Leng Han; Yang Zhou; Chun Geun Lee; Jack A Elias; Soma S K Jyothula; Keshava Rajagopal; Harry Karmouty-Quintana; Michael R Blackburn
Journal:  J Biol Chem       Date:  2019-09-05       Impact factor: 5.157

5.  tRic: a user-friendly data portal to explore the expression landscape of tRNAs in human cancers.

Authors:  Zhao Zhang; Hang Ruan; Chun-Jie Liu; Youqiong Ye; Jing Gong; Lixia Diao; An-Yuan Guo; Leng Han
Journal:  RNA Biol       Date:  2019-08-25       Impact factor: 4.652

6.  RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.

Authors:  Yanjun Qu; Hong Zhu; Congcong Kong; Xin Zheng; Dejun Wang; Xiuwei Chen; Dandan Yuan
Journal:  Clin Transl Oncol       Date:  2022-02-27       Impact factor: 3.405

Review 7.  Targeting mRNA processing as an anticancer strategy.

Authors:  Joana Desterro; Pedro Bak-Gordon; Maria Carmo-Fonseca
Journal:  Nat Rev Drug Discov       Date:  2019-09-25       Impact factor: 84.694

8.  The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.

Authors:  Youqiong Ye; Yu Xiang; Fatma Muge Ozguc; Yoonjin Kim; Chun-Jie Liu; Peter K Park; Qingsong Hu; Lixia Diao; Yanyan Lou; Chunru Lin; An-Yuan Guo; Bingying Zhou; Li Wang; Zheng Chen; Joseph S Takahashi; Gordon B Mills; Seung-Hee Yoo; Leng Han
Journal:  Cell Syst       Date:  2018-03-07       Impact factor: 10.304

9.  PABPN1, a Target of p63, Modulates Keratinocyte Differentiation through Regulation of p63α mRNA Translation.

Authors:  Shakur Mohibi; Jin Zhang; Xinbin Chen
Journal:  J Invest Dermatol       Date:  2020-03-31       Impact factor: 8.551

Review 10.  The Detection and Bioinformatic Analysis of Alternative 3' UTR Isoforms as Potential Cancer Biomarkers.

Authors:  Nitika Kandhari; Calvin A Kraupner-Taylor; Paul F Harrison; David R Powell; Traude H Beilharz
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.